Risk Factors of Acute Kidney Injury in Adult Patients under Veno-Arterial Extracorporeal Membrane Oxygenation Support

Yuan Teng,Yuan Li,Kunyu Li,Qiang Hu,Shujie Yan,Gang Liu,Bingyang Ji,Guodong Gao
DOI: https://doi.org/10.1053/j.jvca.2024.03.038
IF: 2.894
2024-01-01
Journal of Cardiothoracic and Vascular Anesthesia
Abstract:Objective: To investigate the incidence and risk factors of acute kidney injury (AKI) stage 3 in adult patients under veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. Design: A retrospective case-control study. Setting: Single center, Fuwai Hospital. Participants: Adult VA-ECMO patients age >= 18 years and older treated between January 2020 and December 2022 were included. Interventions: The patients were grouped by whether they developed AKI Kidney Disease: Improving Global Outcomes (KDIGO) stage 3 or < 3. Multivariate logistic regression was performed t"o evaluate risk factors of AKI stage 3. Measurements and Main Results: Among enrolled patients, 40 (53.3%) developed AKI stage 3. The in-hospital mortality of AKI stage 3 patients was significantly higher than that of AKI stage < 3 patients (67.5% vs 34.3%; p = 0.004). Multivariate logistic regression analysis revealed that concomitant hypertension (odds ratio [OR], 0.250; 95% confidence interval [CI], 0.063, 0.987), p = 0.048), pre-ECMO hemoglobin (OR, 0.969; 95% CI, 0.947-0.992; p = 0.009), pre-ECMO lactate (OR, 1.173; 95% CI, 1.028-1.339; p = 0.018), and pre-ECMO creatinine (OR, 1.014; 95% CI, 1.003-1.025; p = 0.011) were independent risk factors for AKI stage 3. Conclusions: This study found a high incidence (53.3%) of AKI stage 3 in adult patients with VA-ECMO support and an association with increased in-hospital mortality. Concomitant hypertension, low pre-ECMO hemoglobin, and elevated pre-ECMO lactate and pre-ECMO creatinine were independent risk factors for AKI stage 3 in patients receiving VA-ECMO. It is imperative to identify and adjust these risk factors to enhance outcomes for those supported by VA-ECMO. (c) 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
What problem does this paper attempt to address?